Loading…
3 companies · GEL, thousands · columns ordered by revenue
| Line item | Pardi Medikals | Lotusi | Shik Bebe |
|---|---|---|---|
| Total Revenue | 2,862 | 1,646 | 1,309 |
| Total COGS | -903 | -199 | -746 |
| Gross Profit | 1,958 | 1,446 | 563 |
| Gross Margin | 68.4% | 87.9% | 43.0% |
| Total Operating Expenses | -819 | -1,196 | -476 |
| EBITDA | 1,140 | 250 | 87 |
| EBITDA Margin | 39.8% | 15.2% | 6.6% |
| Total D&A | -8 | -153 | 0 |
| EBIT / Operating Income | 1,132 | 97 | 87 |
| Total Interest Income | 13 | 59 | — |
| Total Interest Expense | -5 | -96 | — |
| Total Other Income | 59 | 75 | -1 |
| Profit Before Tax | 1,199 | 135 | 85 |
| Total Income Tax | 0 | 0 | 0 |
| Net Profit / (Loss) | 1,199 | 135 | 85 |
| Net Margin | 41.9% | 8.2% | 6.5% |
| Company | Sector | EBITDA margin · FY 2022 | Percentile | Sector n |
|---|---|---|---|---|
| Pardi Medikals | (unclassified) | 39.8% | 84th pct | 1230 |
| Lotusi | Healthcare Services | 15.2% | 60th pct | 296 |
| Shik Bebe | FMCG | 6.6% | 53rd pct | 579 |
Percentile is within each company's own sector across the whole FY2022 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.